COVID-19: Hydroxychloroquine Is Not About Trump

President of Doctors for Disasters Preparedness, Dr. Jane Orient, M.D.,  remains a strong advocate of the drug hydroxychloroquine in the fight against the Coronavirus, despite the various labels the drug has been given and its mainstream stigma.

I'm sure you are aware of the politics surrounding the "Trump drug," as opinions about the use of hydroxychloroquine (HCQ) in COVID-19 seem to correlate with support or opposition to President Trump. But that's not the main story, as Dr. Simone Gold pointed out in a Facebook-censored interview with Glenn Beck.


Beltway Insider: Trump Pitches In, Dem/GOP Derail, Jobs, COVID-19, Daisy Coleman, Election


President Trump mentioned HCQ as a potential "game changer" on Mar 21. But the war against HCQ was already on. Until Jan 15, 2020, HCQ was available over the counter in France. After that it became available by prescription only, days before the first Western reports on the epidemic, which had been circulating in Wuhan, China, at least since October 2019. This was part of a multinational effort to restrict HCQ.

Interesting timing: The drug sold as Plaquénil—translating to "plague nil or no plague"—was restricted in the West just before the plague was acknowledged.


President of Doctors for Disaster Preparedness Explains FDA Injunction To Remove Block on Vaccine


The potential value of HCQ has been known since 2005, when the journal Virology published an article entitled "Chloroquine is a potent inhibitor of SARS coronavirus infection and spread." Chloroquine, which works like its derivative HCQ, inhibited viral spread when cells were treated either before or after exposure to SARS-CoV-1, a close relative of SARS-CoV-2, the cause of COVID-19.

Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Disease (NIAID), should certainly be aware of this work. And since NIAID had partially funded research on the virus at the Wuhan Institute of Virology, Fauci was in a position to know a lot.


Association of American Physicians and Surgeons (AAPS) Suggests Different Approach to COVID-19 Surge


The sometimes-masked face of "Science" in the federal response to COVID-19, Fauci is one of the main obstacles to the freedom to prescribe HCQ. He demands randomized controlled trials for HCQ, yet he has called not-yet-approved remdesvir the "standard of care," despite limited evidence

Fauci may be the mask for other influential bureaucrats. At least 10 members of the NIH panel that writes COVID guidelines have a financial interest in Gilead Sciences, the manufacturer of remdesvir.

What if we had a cheap, safe, available preventive and treatment? We could all go to the ball game (like Dr. Fauci), or to a political meeting, church, school, party, or doctor's office. There would be little demand for remdesivir (at least $3,000 for a course of treatment) or for a warp-speed vaccine. The U.S. has already committed to buy 100 million doses of Pfizer's not-yet-tested-or-approved vaccine.


Former President of Association of American Physicians and Surgeons Urges FDA Approval of Hydroxychloroquine to Fight COVID-19


The unprecedented worldwide war on a long-established drug, with fronts in many nations and a coordinated media censorship effort, calls for contact tracing. What are the political and financial relationships of all the decisionmakers in CDC, WHO, FDA, pharmaceutical companies, medical journals, media, social media, academic centers, foundations, and political parties (here and abroad)?        

Link:  https://aapsonline.org/hydroxychloroquine-is-not-about-trump/  

For information on the "natural experiment" of early use vs. nonuse of HCQ—a 79% difference in mortality—see hcqtrial.com.

 

 

 

 

Jane M. Orient, M.D. obtained her undergraduate degrees in chemistry and mathematics from the University of Arizona in Tucson, and her M.D. from Columbia University College of Physicians and Surgeons in 1974. She completed an internal medicine residency at Parkland Memorial Hospital and University of Arizona Affiliated Hospitals and then became an Instructor at the University of Arizona College of Medicine and a staff physician at the Tucson Veterans Administration Hospital. She has been in solo private practice since 1981 and has served as Executive Director of the Association of American Physicians and Surgeons (AAPS) since 1989.

She is currently president of Doctors for Disaster Preparedness. She is the author of YOUR Doctor Is Not In: Healthy Skepticism about National Healthcare, and the second through fifth editions of Sapira's Art and Science of Bedside Diagnosis published by Wolters Kluwer. She authored books for schoolchildren, Professor Klugimkopf's Old-Fashioned English Grammar and Professor Klugimkopf's Spelling Method, published by Robinson Books, and coauthored two novels published as Kindle books, Neomorts and Moonshine. 

More than 100 of her papers have been published in the scientific and popular literature on a variety of subjects including risk assessment, natural and technological hazards and nonhazards, and medical economics and ethics. She is the editor of AAPS News, the Doctors for Disaster Preparedness Newsletter, and Civil Defense Perspectives, and is the managing editor of the Journal of American Physicians and Surgeons.

Haute Tease